Listening to the patient voice: Why developing new dementia treatments is everyone’s jobDeveloping life-changing treatments for dementia is a team effort that takes commitment from all involved, from charities and Share XListening to the patient voice: Why developing new dementia treatments is everyone’s jobhttps://pharmaphorum.com/views-and-analysis/listening-to-the-patient-voice-why-developing-new-dementia-treatments-is-everyones-job/
New HQ to be flagship for UK’s dementia researchThe UK is investing more in its ‘Grand Challenge’ to tackle dementia, with a £40 million investment in Share XNew HQ to be flagship for UK’s dementia researchhttps://pharmaphorum.com/news/new-hq-flagship-uks-dementia-research/
Alzheimer’s research needs international approachNew research initiatives aim to encourage pharma and academia to collaborate on dementia drug discovery, which is a Share XAlzheimer’s research needs international approachhttps://pharmaphorum.com/views-and-analysis/alzheimer-s-research-needs-international-approach/
